欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
NL/H/6446/004
药品名称
Rosuvastatina Aurobindo
活性成分
Rosuvastatin calcium 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Aurobindo Pharma (Portugal), Unip. Lda.
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Finland (FI)
Romania (RO)
Rosuvastatina Aurobindo 40 mg comprimate filmate
Malta (MT)
Rosuvastatin Aurobindo 40mg Film coated tablets
Belgium (BE)
Rosuvastatin AB 40mg filmomhulde tabletten
Luxembourg (LU)
Cyprus (CY)
ROSUVASTATIN AUROBINDO 40MG FC TABS
许可日期
2012/06/28
最近更新日期
2025/06/10
药物ATC编码
C10AA07 rosuvastatin
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
PubAR
|
PAR_NLH6446_Rosuvastatine Aurobindo 5 mg_ 10 mg_ 20 mg and 40 mg_13 August 2025
Date of last change:2025/08/13
PubAR Summary
|
sPAR_NLH6446_Rosuvastatine Aurobindo 5 mg_ 10 mg_ 20 mg and 40 mg_13 August 2025_EN
Date of last change:2025/08/13
Final PL
|
common_pl_clean
Date of last change:2024/10/28
Final Product Information
|
56412_56413_20130902_PAR_GBB
Date of last change:2024/09/06
Final Product Information
|
56414_56415_20130902_PAR_GBB
Date of last change:2024/09/06
Final Labelling
|
common_outer_clean
Date of last change:2024/09/06
Final SPC
|
common_spc_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase